RecruitingNot ApplicableNCT06770101

Suicide Assessment and Feasible Evidence-based Treatments for Youth Living With HIV in Lilongwe

Suicide Assessment and Feasible Evidence-based Treatments for Youth Living With HIV in Lilongwe: SAFETY Planning Pilot Trial


Sponsor

University of Pennsylvania

Enrollment

60 participants

Start Date

Jun 14, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The overall aim of this study is to determine the feasibility, fidelity, acceptability, and preliminary effectiveness of the Friendship Bench +Safety Planning intervention in reducing suicidal ideation and behaviors (SIBs) and improving HIV engagement amongst adolescents living with HIV (ALWH) when compared to augmented usual care.


Eligibility

Min Age: 13 YearsMax Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This study is testing practical, evidence-based treatments for suicide risk that can be used in settings where access to mental health specialists is limited, such as rural areas or low-resource communities. The goal is to find what works best and can be widely implemented. **You may be eligible if...** - You are an adult experiencing elevated suicide risk - You are seeking or receiving care in a setting participating in the study - You are willing to participate and provide consent **You may NOT be eligible if...** - You are currently in a setting where intensive specialized care is immediately available - You are under 18 years old - You are unable to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALBehavioral: Enhanced Friendship Bench + Safety Planning

The protocol will include six sessions, starting with the development of the SP during the first session. Each of the following sessions will include SIBs and suicide risk assessments, SP check-ins and revisions, as well as FB problem-solving to address SIBs and suicide risk. SP+FB will be delivered by selection of young counselors (mixed genders, aged 20-35) who are motivated to work with young people. Counseling sessions will take place in a discrete location within the HIV clinic and be available on weekends. Each structured session lasts 30-45 minutes and conducted in the participant's local language (Chichewa). After 4 sessions of individual therapy, the counselor can refer participants not improving or with suicidal ideation to a supervisor trained in mental health to reassess and manage the case. Case management may include additional counseling or pharmacotherapy, at the discretion of the managing clinician. Participants may also receive text message support and peer-support.

BEHAVIORALAugmented usual care

Care for suicidality in public facilities in Malawi includes options for basic supportive counseling by the primary provider or nurse, medication management by the primary provider, referral to the clinic's psychiatric nurse, or, for acute cases or crises, referral to the psychiatric units at tertiary care hospitals (Bwaila Hospital in Lilongwe District). Nurses and clinicians at the study sites have been specifically trained to use the Tool for Assessment of Suicide Risk for Adolescents (TASR-A) to assess ALWH considered at elevated risk for suicide. For this study, usual care will be augmented by a trained study nurse who will provide mental health evaluation, brief supportive counseling, information, education and support on SIBs, and (if indicated) facilitation of referral to the clinic's psychiatric nurse or to Bwaila Hospital.


Locations(4)

Area 18 Health Center

Lilongwe, Malawi

Area 25 Health Center

Lilongwe, Malawi

Kawale Health Center

Lilongwe, Malawi

Lighthouse Health Center

Lilongwe, Malawi

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06770101


Related Trials